Biophysical and Computational Approaches to Study Ternary Complexes: A ‘Cooperative Relationship’ to Rationalize Targeted Protein Degradation
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Degraders have illustrated that compound‐induced proximity to E3 ubiquitin ligases can prompt the ubiquitination and degradation of disease‐relevant proteins. Hence, this pharmacology is becoming a promising alternative and complement to available therapeutic interventions (e. g., inhibitors). Degraders rely on protein binding instead of inhibition and, hence, they hold the promise to broaden the druggable proteome. Biophysical and structural biology approaches have been the cornerstone of understanding and rationalizing degrader‐induced ternary complex formation. Computational models have now started to harness the experimental data from these approaches with the aim to identify and rationally help design new degraders. This review outlines the current experimental and computational strategies used to study ternary complex formation and degradation and highlights the importance of effective crosstalk between these approaches in the advancement of the targeted protein degradation (TPD) field. As our understanding of the molecular features that govern drug‐induced interactions grows, faster optimizations and superior therapeutic innovations for TPD and other proximity‐inducing modalities are sure to follow.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Accurate prediction of protein structures and interactions using a 3-track network
Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G. R., Wang, J., Cong, Q., Kinch, L. N., Schaeffer, R. D., et al. (2021) · doi:10.1101/2021.06.14.448402 · Cited by 5,549
Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., Lee, M., Lee, T., Duan, Y., Wang, W., et al. (2000) · Accounts of Chemical Research · doi:10.1021/ar000033j · Cited by 4,978
HADDOCK: A Protein−Protein Docking Approach Based on Biochemical or Biophysical Information
Dominguez, C., Boelens, R., & Bonvin, A. M. J. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja026939x · Cited by 3,187
PatchDock and SymmDock: servers for rigid and symmetric docking
Schneidman-Duhovny, D., Inbar, Y., Nussinov, R., & Wolfson, H. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki481 · Cited by 3,018
NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells
Dixon, A. S., Schwinn, M. K., Hall, M. P., Zimmerman, K., Otto, P., Lubben, T. H., Butler, B. L., Binkowski, B. F., Machleidt, T., Kirkland, T. A., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00753 · Cited by 1,405
Structural basis of PROTAC cooperative recognition for selective protein degradation
Gadd, M. S., Testa, A., Lucas, X., Chan, K.-H., Chen, W., Lamont, D. J., Zengerle, M., & Ciulli, A. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2329 · Cited by 1,242
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Zengerle, M., Chan, K.-H., & Ciulli, A. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00216 · Cited by 1,056
Targeted protein degradation: expanding the toolbox
Schapira, M., Calabrese, M. F., Bullock, A. N., & Crews, C. M. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0047-y · Cited by 960
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Bondeson, D. P., Smith, B. E., Burslem, G. M., Buhimschi, A. D., Hines, J., Jaime-Figueroa, S., Wang, J., Hamman, B. D., Ishchenko, A., & Crews, C. M. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.09.010 · Cited by 923
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Khan, S., Zhang, X., Lv, D., Zhang, Q., He, Y., Zhang, P., Liu, X., Thummuri, D., Yuan, Y., Wiegand, J. S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0668-z · Cited by 688
Plasticity in binding confers selectivity in ligand-induced protein degradation
Nowak, R. P., DeAngelo, S. L., Buckley, D., He, Z., Donovan, K. A., An, J., Safaee, N., Jedrychowski, M. P., Ponthier, C. M., Ishoey, M., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0055-y · Cited by 615
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
Farnaby, W., Koegl, M., Roy, M. J., Whitworth, C., Diers, E., Trainor, N., Zollman, D., Steurer, S., Karolyi-Oezguer, J., Riedmueller, C., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0294-6 · Cited by 562
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
Smith, B. E., Wang, S. L., Jaime-Figueroa, S., Harbin, A., Wang, J., Hamman, B. D., & Crews, C. M. (2019) · Nature Communications · doi:10.1038/s41467-018-08027-7 · Cited by 517
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins
Buckley, D. L., Raina, K., Darricarrere, N., Hines, J., Gustafson, J. L., Smith, I. E., Miah, A. H., Harling, J. D., & Crews, C. M. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00442 · Cited by 488
Winter, G. E., Mayer, A., Buckley, D. L., Erb, M. A., Roderick, J. E., Vittori, S., Reyes, J. M., di Iulio, J., Souza, A., Ott, C. J., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.004 · Cited by 465
Delineating the role of cooperativity in the design of potent PROTACs for BTK
Zorba, A., Nguyen, C., Xu, Y., Starr, J., Borzilleri, K., Smith, J., Zhu, H., Farley, K. A., Ding, W., Schiemer, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803662115 · Cited by 419
Targeted protein degraders crowd into the clinic
Mullard, A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/d41573-021-00052-4 · Cited by 409
SPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate
Roy, M. J., Winkler, S., Hughes, S. J., Whitworth, C., Galant, M., Farnaby, W., Rumpel, K., & Ciulli, A. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00092 · Cited by 386
Zoppi, V., Hughes, S. J., Maniaci, C., Testa, A., Gmaschitz, T., Wieshofer, C., Koegl, M., Riching, K. M., Daniels, D. L., Spallarossa, A., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01413 · Cited by 336
Protein-Protein Docking: From Interaction to Interactome
Vakser, I. A. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.08.033 · Cited by 318
Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models
Silva, M. C., Ferguson, F. M., Cai, Q., Donovan, K. A., Nandi, G., Patnaik, D., Zhang, T., Huang, H.-T., Lucente, D. E., Dickerson, B. C., et al. (2019) · eLife · doi:10.7554/elife.45457 · Cited by 283
Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity
Imaide, S., Riching, K. M., Makukhin, N., Vetma, V., Whitworth, C., Hughes, S. J., Trainor, N., Mahan, S. D., Murphy, N., Cowan, A. D., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00878-4 · Cited by 251
Maniaci, C., Hughes, S. J., Testa, A., Chen, W., Lamont, D. J., Rocha, S., Alessi, D. R., Romeo, R., & Ciulli, A. (2017) · Nature Communications · doi:10.1038/s41467-017-00954-1 · Cited by 245
Bulatov, E., & Ciulli, A. (2015) · Biochemical Journal · doi:10.1042/bj20141450 · Cited by 237
PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes
Zaidman, D., Prilusky, J., & London, N. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00589 · Cited by 224
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
Faust, T. B., Yoon, H., Nowak, R. P., Donovan, K. A., Li, Z., Cai, Q., Eleuteri, N. A., Zhang, T., Gray, N. S., & Fischer, E. S. (2020) · Nature Chemical Biology · doi:10.1038/s41589-019-0378-3 · Cited by 218
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction
Simonetta, K. R., Taygerly, J., Boyle, K., Basham, S. E., Padovani, C., Lou, Y., Cummins, T. J., Yung, S. L., von Soly, S. K., Kayser, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09358-9 · Cited by 217
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity
Pillow, T. H., Adhikari, P., Blake, R. A., Chen, J., Del Rosario, G., Deshmukh, G., Figueroa, I., Gascoigne, K. E., Kamath, A. V., Kaufman, S., et al. (2020) · ChemMedChem · doi:10.1002/cmdc.201900497 · Cited by 216
Chasing molecular glue degraders: screening approaches
Domostegui, A., Nieto-Barrado, L., Perez-Lopez, C., & Mayor-Ruiz, C. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00197g · Cited by 200
Self-citationIn Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and Application
Drummond, M. L., & Williams, C. I. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00872 · Cited by 199
Drummond, M. L., Henry, A., Li, H., & Williams, C. I. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00897 · Cited by 166
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,
Lv, D., Pal, P., Liu, X., Jia, Y., Thummuri, D., Zhang, P., Hu, W., Pei, J., Zhang, Q., Zhou, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27210-x · Cited by 158
Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta
Bai, N., Miller, S. A., Andrianov, G. V., Yates, M., Kirubakaran, P., & Karanicolas, J. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01451 · Cited by 157
Zhao, Q., Ren, C., Liu, L., Chen, J., Shao, Y., Sun, N., Sun, R., Kong, Y., Ding, X., Zhang, X., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01264 · Cited by 134
Integrative Modeling of PROTAC-Mediated Ternary Complexes
Weng, G., Li, D., Kang, Y., & Hou, T. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01576 · Cited by 130
Defining molecular glues with a dual-nanobody cannabidiol sensor
Cao, S., Kang, S., Mao, H., Yao, J., Gu, L., & Zheng, N. (2022) · Nature Communications · doi:10.1038/s41467-022-28507-1 · Cited by 125
Acute pharmacological degradation of Helios destabilizes regulatory T cells
Wang, E. S., Verano, A. L., Nowak, R. P., Yuan, J. C., Donovan, K. A., Eleuteri, N. A., Yue, H., Ngo, K. H., Lizotte, P. H., Gokhale, P. C., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00802-w · Cited by 124
Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes
Schiemer, J., Horst, R., Meng, Y., Montgomery, J. I., Xu, Y., Feng, X., Borzilleri, K., Uccello, D. P., Leverett, C., Brown, S., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00686-2 · Cited by 113
Quantitating drug-target engagement in single cells in vitro and in vivo
Dubach, J. M., Kim, E., Yang, K., Cuccarese, M., Giedt, R. J., Meimetis, L. G., Vinegoni, C., & Weissleder, R. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2248 · Cited by 87
Bai, N., Riching, K. M., Makaju, A., Wu, H., Acker, T. M., Ou, S.-C., Zhang, Y., Shen, X., Bulloch, D. N., Rui, H., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101653 · Cited by 77
Bellenie, B. R., Cheung, K.-M. J., Varela, A., Pierrat, O. A., Collie, G. W., Box, G. M., Bright, M. D., Gowan, S., Hayes, A., Rodrigues, M. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02076 · Cited by 74
Li, W., Zhang, J., Guo, L., & Wang, Q. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01150 · Cited by 63
In Silico Modeling and Scoring of PROTAC-Mediated Ternary Complex Poses
Liao, J., Nie, X., Unarta, I. C., Ericksen, S. S., & Tang, W. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02155 · Cited by 62
Payne, N. C., Maksoud, S., Tannous, B. A., & Mazitschek, R. (2022) · Cell Chemical Biology · doi:10.1016/j.chembiol.2022.05.003 · Cited by 44
Targeting oncoproteins with a positive selection assay for protein degraders
Koduri, V., Duplaquet, L., Lampson, B. L., Wang, A. C., Sabet, A. H., Ishoey, M., Paulk, J., Teng, M., Harris, I. S., Endress, J. E., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd6263 · Cited by 44
Identification and characterization of cancer vulnerabilities via targeted protein degradation
Mayor-Ruiz, C., & Winter, G. E. (2019) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2018.12.003 · Cited by 33
Self-citationElucidating the druggability of the human proteome with eFindSite
Kana, O., & Brylinski, M. (2019) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-019-00197-w · Cited by 27
Dixon, T., MacPherson, D., Mostofian, B., Dauzhenka, T., Lotz, S., McGee, D., Shechter, S., Shrestha, U. R., Wiewiora, R., McDargh, Z. A., et al. (2021) · doi:10.1101/2021.09.26.461830 · Cited by 7
Research works printed but not linked: 95
- Bekes M., 2022, Nat. Rev. Drug Discovery, 21, 181, 10.1038/s41573-021-00371-6 · DOI · Paper page
- L. Nieto-Barrado A. Domostegui C. Mayor-Ruiz Inducing Targeted Protein Degradation Wiley-VCH2023 pp. 177–204. · DOI
- Farnaby W., 2021, Curr. Opin. Pharmacol., 57, 175, 10.1016/j.coph.2021.02.009 · DOI · Paper page
- Lipinski C. A., 2001, Adv. Drug Delivery Rev., 46, 3, 10.1016/S0169-409X(00)00129-0 · DOI · Paper page
- Ren S., 2010, Cell. Physiol. Biochem., 26, 97, 10.1159/000315110 · DOI
- Rui H., 2023, RSC Chemical Biology, 4, 192, 10.1039/D2CB00207H · DOI
- Sabatini D. M., 1994, Cell, 78, 35, 10.1016/0092-8674(94)90570-3 · DOI · Paper page
- Chan K. H., 2018, J. Med. Chem., 61, 504, 10.1021/acs.jmedchem.6b01912 · DOI · Paper page
- Testa A., 2018, J. Am. Chem. Soc., 140, 9299, 10.1021/jacs.8b05807 · DOI · Paper page
- Han X., 2019, J. Med. Chem., 62, 11218, 10.1021/acs.jmedchem.9b01393 · DOI · Paper page
- Copeland R. A., 2016, Nat. Rev. Drug Discovery, 15, 87, 10.1038/nrd.2015.18 · DOI · Paper page
- Rosenberg S. C., 2023, Cell Chem. Biol.
- Wurz R. P., 2018, J. Med. Chem., 61, 453, 10.1021/acs.jmedchem.6b01781 · DOI · Paper page
- Du G., 2022, Cell Chem. Biol., 29, 1470, 10.1016/j.chembiol.2022.08.003 · DOI
- Petzold G., 2016, Nature, 532, 127, 10.1038/nature16979 · DOI · Paper page
- Mayor-Ruiz C., 2021, Nat. Chem. Biol., 17, 361, 10.1038/s41589-021-00735-4 · doi:10.1038/s41589-021-00735-4
- Glickman J. F., 2002, J. Biomol. Screening, 7, 3, 10.1177/108705710200700102 · DOI · Paper page
- Eglen R. M., 2008, Curr. Chem. Genomics, 1, 2, 10.2174/1875397300801010002 · DOI · Paper page
- Stevers L. M., 2022, Nat. Commun., 13, 3586, 10.1038/s41467-022-31206-6 · DOI
- Falcicchio M., 2021, Chem. Sci., 12, 12985, 10.1039/D1SC02120F · DOI
- Testa A., 2020, Angew. Chem. Int. Ed. Engl., 59, 1727, 10.1002/anie.201914396 · DOI · Paper page
- Centorrino F., 2022, Curr Res Struct Biol, 4, 21, 10.1016/j.crstbi.2021.12.003 · DOI
- Slabicki M., 2020, Nature, 585, 293, 10.1038/s41586-020-2374-x · DOI · Paper page
- Stevers L. M., 2016, Proc. Natl. Acad. Sci. USA, 113, E1152, 10.1073/pnas.1516631113 · DOI · Paper page
- Bussiere D. E., 2020, Nat. Chem. Biol., 16, 15, 10.1038/s41589-019-0411-6 · DOI · Paper page
- Fisher S. L., 2018, Curr. Opin. Chem. Biol., 44, 47, 10.1016/j.cbpa.2018.05.004 · DOI · Paper page
- Connaris H., 2009, J. Biol. Chem., 284, 7339, 10.1074/jbc.M807398200 · DOI
- Kofink C., 2022, Nat. Commun., 13, 5969, 10.1038/s41467-022-33430-6 · DOI · Paper page
- Guillory X., 2020, J. Med. Chem., 63, 6694, 10.1021/acs.jmedchem.9b01942 · DOI
- Hartman A. M., 2020, ACS Med. Chem. Lett., 11, 1041, 10.1021/acsmedchemlett.9b00541 · DOI
- Petrilli W. L., 2021, Cell Chem. Biol., 28, 243, 10.1016/j.chembiol.2021.01.019 · DOI
- Bartoschik T., 2021, Methods Mol. Biol., 2365, 115, 10.1007/978-1-0716-1665-9_6 · DOI
- Beveridge R., 2020, ACS Cent. Sci., 6, 1223, 10.1021/acscentsci.0c00049 · DOI
- Bellamy-Carter J., 2021, Chem. Sci., 12, 10724, 10.1039/D1SC01450A · DOI
- Kenanova D. N., 2023, bioRxiv, 2023
- Castro G. V., 2022, RSC Med. Chem., 13, 98, 10.1039/D1MD90045E · doi:10.1039/d1md90045e
- Riching K. M., 2018, ACS Chem. Biol., 13, 2758, 10.1021/acschembio.8b00692 · DOI · Paper page
- Mahan S. D., 2021, Methods Mol. Biol., 2365, 151, 10.1007/978-1-0716-1665-9_8 · DOI
- Mason J. W., 2022, bioRxiv, 2022
- Chung C. I., 2018, Anal. Chem., 90, 14287, 10.1021/acs.analchem.8b03476 · DOI · Paper page
- Kaji T., 2020, Sci. Rep., 10, 3088, 10.1038/s41598-020-59966-5 · DOI
- Chernobrovkin A. L., 2021, SLAS Discov, 26, 534, 10.1177/2472555220984372 · DOI
- Luchinat E., 2020, Angew. Chem. Int. Ed. Engl., 59, 6535, 10.1002/anie.201913436 · DOI
- Dale N. C., 2019, F. Bioeng. Biotech., 7, 56, 10.3389/fbioe.2019.00056 · DOI · Paper page
- Brand M., 2019, Cell Chem. Biol., 26, 300, 10.1016/j.chembiol.2018.11.006 · DOI · Paper page
- Yang F., 2023, ChemBioChem, 24, 10.1002/cbic.202200680 · DOI
- Banning C., 2010, PLoS One, 5, 10.1371/journal.pone.0009344 · DOI · Paper page
- Margineanu A., 2016, Sci. Rep., 6, 28186, 10.1038/srep28186 · DOI
- Shyu Y. J., 2008, Nat. Protoc., 3, 1693, 10.1038/nprot.2008.157 · DOI
- Serebryannyy L. A., 2019, Methods, 157, 80, 10.1016/j.ymeth.2018.11.004 · DOI
- Schwalm M. P., 2023, bioRxiv, 2023
- Hsia O., 2023, bioRxiv, 2023
- Li Y.-D., 2023, bioRxiv, 2023
- Lee Y., 2020, Angew. Chem. Int. Ed., 59, 17548, 10.1002/anie.202005004 · DOI
- 2020, Angew. Chem., 132, 17701, 10.1002/ange.202005004 · DOI
- Baek M., 2021, Science, 373, 871, 10.1126/science.abj8754 · doi:10.1126/science.abj8754 · Paper page
- Evans R., 2021, bioRxiv, 2021
- Oliva R., 2015, Molecules, 20, 12045, 10.3390/molecules200712045 · doi:10.3390/molecules200712045
- Kaczor A. A., 2018, Methods Mol. Biol., 1762, 285, 10.1007/978-1-4939-7756-7_15 · DOI
- Schiedel M., 2018, J. Med. Chem., 61, 482, 10.1021/acs.jmedchem.6b01872 · DOI · Paper page
- Gray J. J., 2003, J. Mol. Biol., 331, 281, 10.1016/S0022-2836(03)00670-3 · DOI · Paper page
- Ramírez-Aportela E., 2016, Bioinformatics, 32, 2386, 10.1093/bioinformatics/btw141 · DOI
- Dolle A., 2021, J. Med. Chem., 64, 10682, 10.1021/acs.jmedchem.1c00146 · DOI · Paper page
- Kozakov D., 2017, Nature Protocols, 12, 255, 10.1038/nprot.2016.169 · DOI · Paper page
- Pereira G. P., 2023, bioRxiv, 2023
- Zhu C. L., 2022, Eur. J. Med. Chem., 238, 10.1016/j.ejmech.2022.114459 · DOI
- Hollingsworth S. A., 2018, Neuron, 99, 1129, 10.1016/j.neuron.2018.08.011 · DOI · Paper page
- Liu X., 2018, Expert Opin. Drug Discovery, 13, 23, 10.1080/17460441.2018.1403419 · DOI · Paper page
- Mansoor S., 2022, Comput. Struct. Biotechnol. J., 20, 925, 10.1016/j.csbj.2022.01.016 · DOI
- Arnatt C. K., 2016, Bioorg. Med. Chem., 24, 5969, 10.1016/j.bmc.2016.09.059 · DOI
- Pérez-Benito L., 2018, Bioinformatics, 34, 3857, 10.1093/bioinformatics/bty422 · DOI · Paper page
- Weerakoon D., 2022, J. Chem. Inf. Model., 62, 340, 10.1021/acs.jcim.1c01036 · DOI
- Dixon T., 2022, Nat. Commun., 13, 5884, 10.1038/s41467-022-33575-4 · DOI · Paper page
- Rao A., 2022, bioRxiv, 2022
- Srinivasan J., 1998, J. Biomol. Struct. Dyn., 16, 671, 10.1080/07391102.1998.10508279 · DOI · Paper page
- Srinivasan J., 1998, J. Am. Chem. Soc., 120, 9401, 10.1021/ja981844+ · DOI · Paper page
- Wang E., 2019, Chem. Rev., 119, 9478, 10.1021/acs.chemrev.9b00055 · DOI · Paper page
- Genheden S., 2015, Expert Opin. Drug Discovery, 10, 449, 10.1517/17460441.2015.1032936 · DOI · Paper page
- Tuccinardi T., 2021, Expert Opin. Drug Discovery, 16, 1233, 10.1080/17460441.2021.1942836 · doi:10.1080/17460441.2021.1942836
- Alexandrov V., 2005, Protein Sci., 14, 633, 10.1110/ps.04882105 · DOI · Paper page
- Drummond M. L., 2020, J. Chem. Inf. Model., 60, 5234, 10.1021/acs.jcim.0c00897 · DOI · Paper page
- Murakami Y., 2022, RSC Med. Chem., 13, 1495, 10.1039/D2MD00284A · DOI
- Niu T., 2022, Eur. J. Med. Chem., 228, 10.1016/j.ejmech.2021.114012 · DOI
- Zheng S., 2022, Nat. Machine Intelligence, 4, 739, 10.1038/s42256-022-00527-y · DOI
- Dixon T., 2022, Nat. Communications, 13, 5884, 10.1038/s41467-022-33575-4 · DOI · Paper page
- Borrelli K. W., 2005, J. Chem. Theory Comput., 1, 1304, 10.1021/ct0501811 · DOI · Paper page
- Jorgensen W. L., 2005, J. Comput. Chem., 26, 1689, 10.1002/jcc.20297 · DOI · Paper page
- Berman H. M., 2000, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235 · DOI · Paper page
- Weng G., 2023, Nucleic Acids Res., 51, D1367, 10.1093/nar/gkac946 · DOI · Paper page
- Zhang W., 2022, Genomics Proteomics Bioinf.
- Poongavanam V., 2023, ACS Omega, 8, 5901, 10.1021/acsomega.2c07717 · DOI
- Poongavanam V., 2022, J. Med. Chem., 65, 13029, 10.1021/acs.jmedchem.2c00877 · DOI · Paper page
- Ignatov M., 2023, J. Am. Chem. Soc.
- Antolin A. A., 2023, Nucleic Acids Res., 51, D1492, 10.1093/nar/gkac909 · DOI
- Park D., 2023, ACS Bio & Med Chem Au, 3, 74, 10.1021/acsbiomedchemau.2c00037 · DOI
Cited by
Biolayer interferometry and its applications in drug discovery and development
Jug, A., Bratkovič, T., & Ilaš, J. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117741 · Cited by 107
Adhikari, B., Schneider, K., Diebold, M., Sotriffer, C., & Wolf, E. (2024) · eLife · doi:10.7554/elife.98450 · Cited by 4
Metadata
- Authors
- Ward, J. A., Perez‐Lopez, C., & Mayor‐Ruiz, C.
- Venue
- ChemBioChem
- Publisher
- Wiley
- Published
- 2023-04-21
- Volume
- 24
- Issue
- 10
- Pages
- e202300163-e202300163
- ISSN
- 1439-4227 (ISSN-L)
- 1439-7633
- OpenAlex
- W4362601635
- Cited by
- 47
- References
- 49
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- Mark Foundation For Cancer Research
- Ministerio de Ciencia e Innovación
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.